Non-parametric methods for cost-effectiveness analysis: The central limit theorem and the bootstrap compared

Health Economics

Volumn 19, Issue 3, 2010, Pages 316-333

  Nixon, Richard M ^a   Wonderling, David ^b   Grieve, Richard D ^c  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bootstrap; Central limit theorem; Confidence ellipse; Cost effectiveness acceptability curve; Incremental net benefit

Indexed keywords

ARTICLE; BOOTSTRAPPING; CENTRAL LIMIT THEOREM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITY OF LIFE; SAMPLE SIZE; SIMULATION; THEORY;

CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; MODELS, ECONOMIC; MONTE CARLO METHOD; SAMPLE SIZE; UNCERTAINTY;

EID: 76149141566     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.1477     Document Type: Article

References (32)

1. Briggs A, Fenn P. 1998. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Economics 7: 723-740.
2. Briggs A, Nixon R, Dixon S, Thompson S. 2005. Parametric modelling of cost data: some simulation evidence. Health Economics 14: 421-428.
3. Briggs AH. 2003. Statistical Methods for Cost-effectiveness Research: A Guide to Current Issues and Future Developments. OHE: London.
4. Briggs AH, Mooney CZ, Wonderling DE. 1999. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. Statistics in Medicine 18: 3245-3262.
5. Cochran WG. 1977. Sampling Techniques. Wiley: New York.
6. Cooper NJ, Sutton AJ, Abrams KR, Turner D, Wailoo A. 2004. Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Economics 13: 203-226.
7. Davison AC, Hinkley DV. 1997. Bootstrap Methods and Their Application (1st edn). Cambridge University Press: Cambridge.
8. DeGroot MH. 1986. Probability and Statistics (2nd edn). Addison-Wesley: Reading, MA.
9. Feller W. 1968. An Introduction to Probability Theory and Its Applications. Wiley: New York.
10. Fenwick E, Claxton K, Sculpher M. 2001. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics 10: 779-787.
11. Fenwick E, O'Brien BJ, Briggs A. 2004. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Economics 13: 405-415.
12. Glick HA, Doshi JA, Sonnad SS, Polsky D. 2007. Economic Evaluation in Clinical Trials (1st edn). Oxford University Press: Oxford.
13. Heitjan DF. 2000. Fieller's method and net health benefits. Health Economics 9: 327-335.
14. Hoch JS, Briggs AH, Willan AR. 2002. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics 11: 415-430.
15. Kotz S, Balakrishnan N, Johnson NL. 2000. Continuous Multivariate Distributions, Models and Applications (2nd edn). Wiley: New York.
16. Laska EM, Meisner M, Siegel C, Wanderling J. 2001. Statistical cost-effectiveness analysis of two treatments based on net health benefits. Statistics in Medicine 20: 1279-1302.
17. Lothgren M, Zethraeus N. 2000. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Economics 9: 623-630.
18. Murdoch DJ, Chow ED. 1996. A graphical display of large correlation matrices. American Statistician 50: 178-180.
19. National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal, 2008. Available from: http://www.nice.org.uk.
20. Nixon RM, Thompson SG. 2005. Methods for incorporating covariate adjustment, subgroup analysis and betweencentre differences into cost-effectiveness evaluations. Health Economics 14: 1217-1229.
21. O'Hagan A, Stevens JW. 2001. A framework for cost-effectiveness analysis from clinical trial data. Health Economics 10: 303-315.
22. O'Hagan A, Stevens JW. 2003. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? Health Economics 12: 33-49.
23. Sculpher MJ, Claxton K, Drummond M, McCabe C. 2006. Whither trial-based economic evaluation for health care decision making? Health Economics 15: 677-687.
24. Stinnett AA, Mullahy J. 1998. Net health benefits: a new framework for the analysis of uncertainty in costeffectiveness analysis. Medical Decision Making 18: S68-S80.
25. Tambour M, Zethraeus N, Johannesson M. 1998. A note on confidence intervals in cost-effectiveness analysis. International Journal of Technology Assessment in Health Care 14: 467-471.
26. van Hout BA, Al MJ, Gordon GS, Ruten FFH. 1994. Costs, effects and C/E-ratios alongside a clinical-trial. Health Economics 3: 309-319.
27. Wand MP, Jones MC. 1995. Kernel Smoothing (1st edn). Chapman & Hall: London.
28. Willan AR, Briggs A. 2006. Statistical Analysis of Cost-effectiveness Data. Wiley: Chichester, UK.
29. Willan AR, Briggs AH, Hoch JS. 2004. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Economics 13: 461-475.
30. Willan AR, Chen EB, Cook RJ, Lin DY. 2003. Incremental net benefit in randomized clinical trials with quality-adjusted survival. Statistics in Medicine 22: 353-362.
31. Willan AR, Lin DY. 2001. Incremental net benefit in randomized clinical trials. Statistics in Medicine 20: 1563-1574.
32. Wonderling D, Vickers AJ, Grieve R, McCarney R. 2004. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. British Medical Journal 328: 747-749.